Akademik Veri Yönetim Sistemi
Prognostic and Diagnostic Markers in Diseases, NOVA Publications , ss.331-340, 2026
Biomarkers are molecules that help clinicians diagnose existing diseases and predict their progression. Biomarkers also offer hope for clinicians in illuminating disease pathogenesis and determining patient prognosis. Biomarkers may also have disease-specific and timesaving potential. Especially in elderly patients with additional diseases, markers sensitive to inflammation, hematological changes, and vascular structure may help clinicians in diagnosis, treatment, and follow-up. New markers routinely used and tested in cardiovascular, cerebrovascular, allergic, infectious, genetic, and neoplastic patient groups that are frequently seen in the community may be beneficial in reducing this patient burden. In our world, with the last century, in the reality of an aging society, especially in the neurological patient group, biomarkers can have a positive effect on public health, as there is a risk of recurrence. Patient management is important in endocrine diseases with acute and long-term complications such as diabetes. In recent years, in parallel with technological developments, the development process of biomarkers that shorten the evaluation process and the treatment period according to the active allergen in allergy-related diseases that concern the whole society and reduce the quality of life is accelerating. Rapid diagnosis and determination of appropriate treatment options are also important for bacterial and viral infections that spread rapidly in the community. This process directly affects the prognosis of patients. In particular, the COVID-19 pandemic has presented numerous studies to the literature showing that biomarkers can be useful in predicting mortality in patients.